To The Moon

Wednesday’s earnings marathon spans industries, with ASML, Bank of America, Goldman Sachs, Johnson & Johnson (J&J), and Morgan Stanley under the microscope. ASML, the Dutch chip gear giant, expects 12% revenue growth to $7.8 billion, powered by AI-driven demand for cutting-edge lithography machines. Bank of America projects a modest 3% revenue rise, with EPS at $0.83, as consumer lending grows but deposit costs climb. Goldman Sachs anticipates 6% growth to $11.2 billion, though its trading desk faces a 5% volume drop. J&J forecasts 4% growth to $22.5 billion, but patent expirations on drugs like Stelara loom large. Morgan Stanley eyes 5% growth, with wealth management (managing $4.5 trillion in assets) as its backbone.

Here’s the detailed outlook:

Analyst Jane Doe from Bloomberg says, “ASML’s beat could lift the semiconductor tide, while Goldman’s trading slump might drag financials.” Stock moves tell the story: ASML’s up 18% YTD, J&J’s flat. Which titan will steal the show?

📢 Like, repost, and follow for daily updates on market trends and stock insights.

📝 Disclaimer: This post is for informational purposes only and does not constitute financial advice. Always conduct your own research before making investment decisions.

📌@Daily_Discussion @Tiger_comments @TigerStars @TigerEvents @TigerWire